Investigating the effect of quince oxymel on non-alcoholic fatty liver

Phase 3

Recruiting

• Conditions: on-alcoholic fatty liver.; Fatty (change of) liver, not elsewhere classified; K76.0

• Registration Number: IRCT20221202056689N1
• Lead Sponsor: Ghoum University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Patients between the ages of 20 and 65 years
are diagnosed with grade 2 or higher fatty liver based on the ultrasound report
liver enzymes that are higher than the normal level.

Exclusion Criteria

Having diabetes
Viral hepatitis and autoimmune hepatitis
Having metabolic diseases such as Wilson's disease and hemochromatosis
History of alcohol consumption and alcoholic beverages
Liver transplant at some point in the past
Taking any type of medicine to treat fatty liver in the past one month
The patient's unwillingness to continue the plan
Severe allergy or drug complication
Pregnancy and breastfeeding
Taking Varfarin, heparin compounds and anticoagulant drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
on-alcoholic fatty liver grade. Timepoint: At the beginning of the study (before the start of the intervention) and twelve weeks after the intervention. Method of measurement: ultrasound device.;Alanine aminotransferase enzyme. Timepoint: ?? ?????? ?????? ( ??? ?? ???? ?????? ) ? ?????? ???? ??? ?? ??????. Method of measurement: Measuring the serum level of alanine aminotransferase enzyme in peripheral blood samples.;Aspartate aminotransferase. Timepoint: ?? ?????? ?????? ( ??? ?? ???? ?????? ) ? ?????? ???? ??? ?? ??????. Method of measurement: ?????? ???? ??? ???? ????? ???????? ????? ????????? ?? ????? ??? ?????.